Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicaid | 15 | 2023 | 268 | 5.220 |
Why?
|
| Opioid-Related Disorders | 13 | 2023 | 367 | 5.100 |
Why?
|
| Buprenorphine | 4 | 2022 | 135 | 2.750 |
Why?
|
| Analgesics, Opioid | 8 | 2023 | 500 | 2.740 |
Why?
|
| United States | 40 | 2023 | 5208 | 2.360 |
Why?
|
| Drug Prescriptions | 6 | 2022 | 89 | 2.050 |
Why?
|
| Mental Health Services | 7 | 2020 | 233 | 2.010 |
Why?
|
| Patient Protection and Affordable Care Act | 5 | 2022 | 62 | 1.930 |
Why?
|
| Mental Disorders | 9 | 2020 | 445 | 1.880 |
Why?
|
| Substance-Related Disorders | 6 | 2023 | 671 | 1.750 |
Why?
|
| Insurance Coverage | 5 | 2022 | 108 | 1.600 |
Why?
|
| Insurance, Health | 6 | 2022 | 132 | 1.580 |
Why?
|
| Psychiatry | 2 | 2022 | 116 | 1.490 |
Why?
|
| Cannabis | 2 | 2023 | 149 | 1.410 |
Why?
|
| Adolescent | 24 | 2023 | 6900 | 1.320 |
Why?
|
| Health Surveys | 4 | 2019 | 261 | 1.310 |
Why?
|
| Health Services Accessibility | 7 | 2023 | 428 | 1.240 |
Why?
|
| Healthcare Disparities | 3 | 2020 | 269 | 1.210 |
Why?
|
| Telemedicine | 5 | 2023 | 453 | 1.160 |
Why?
|
| Humans | 53 | 2023 | 54391 | 1.020 |
Why?
|
| Depressive Disorder, Major | 2 | 2023 | 159 | 0.980 |
Why?
|
| Young Adult | 18 | 2020 | 4318 | 0.980 |
Why?
|
| Female | 36 | 2023 | 28471 | 0.970 |
Why?
|
| Child | 14 | 2023 | 7368 | 0.910 |
Why?
|
| Adult | 26 | 2022 | 14207 | 0.860 |
Why?
|
| Insurance, Psychiatric | 2 | 2019 | 6 | 0.860 |
Why?
|
| Antipsychotic Agents | 2 | 2022 | 241 | 0.850 |
Why?
|
| Logistic Models | 7 | 2023 | 991 | 0.710 |
Why?
|
| Child Abuse | 1 | 2022 | 170 | 0.700 |
Why?
|
| Financing, Personal | 1 | 2019 | 16 | 0.700 |
Why?
|
| Inappropriate Prescribing | 1 | 2019 | 20 | 0.690 |
Why?
|
| Adolescent Health Services | 1 | 2019 | 11 | 0.690 |
Why?
|
| Pandemics | 6 | 2023 | 594 | 0.680 |
Why?
|
| Health Services | 2 | 2022 | 80 | 0.680 |
Why?
|
| Emergency Service, Hospital | 3 | 2019 | 543 | 0.670 |
Why?
|
| Opiate Substitution Treatment | 4 | 2022 | 80 | 0.670 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2018 | 17 | 0.670 |
Why?
|
| Adolescent Behavior | 2 | 2018 | 113 | 0.660 |
Why?
|
| Obesity | 4 | 2020 | 1203 | 0.650 |
Why?
|
| Depression, Postpartum | 1 | 2018 | 42 | 0.650 |
Why?
|
| Self-Injurious Behavior | 1 | 2018 | 29 | 0.640 |
Why?
|
| Male | 22 | 2020 | 27347 | 0.630 |
Why?
|
| Schools | 1 | 2019 | 177 | 0.620 |
Why?
|
| Family | 1 | 2019 | 191 | 0.620 |
Why?
|
| Pregnancy | 12 | 2023 | 2639 | 0.610 |
Why?
|
| Patient Compliance | 1 | 2018 | 247 | 0.600 |
Why?
|
| Middle Aged | 16 | 2021 | 13082 | 0.600 |
Why?
|
| Heroin Dependence | 1 | 2017 | 43 | 0.590 |
Why?
|
| Prescription Drug Misuse | 1 | 2017 | 30 | 0.580 |
Why?
|
| Inpatients | 1 | 2018 | 206 | 0.570 |
Why?
|
| Medically Uninsured | 1 | 2016 | 51 | 0.550 |
Why?
|
| Child of Impaired Parents | 1 | 2016 | 46 | 0.550 |
Why?
|
| Alcoholism | 1 | 2018 | 249 | 0.540 |
Why?
|
| Health Expenditures | 1 | 2016 | 67 | 0.540 |
Why?
|
| Mental Health | 2 | 2019 | 245 | 0.540 |
Why?
|
| Asthma | 2 | 2020 | 293 | 0.540 |
Why?
|
| Rural Population | 1 | 2020 | 598 | 0.530 |
Why?
|
| Health Status Disparities | 4 | 2022 | 219 | 0.530 |
Why?
|
| Postpartum Period | 3 | 2023 | 117 | 0.530 |
Why?
|
| Quinolines | 1 | 2015 | 40 | 0.510 |
Why?
|
| Acetates | 1 | 2015 | 50 | 0.500 |
Why?
|
| Hospitalization | 2 | 2018 | 704 | 0.500 |
Why?
|
| Self Concept | 1 | 2013 | 71 | 0.460 |
Why?
|
| Body Image | 1 | 2013 | 22 | 0.460 |
Why?
|
| Parents | 1 | 2016 | 346 | 0.440 |
Why?
|
| Self Report | 1 | 2013 | 205 | 0.430 |
Why?
|
| Age Factors | 4 | 2020 | 1199 | 0.430 |
Why?
|
| Suicidal Ideation | 2 | 2023 | 96 | 0.400 |
Why?
|
| Overweight | 2 | 2013 | 240 | 0.390 |
Why?
|
| Parenting | 2 | 2023 | 114 | 0.380 |
Why?
|
| Databases, Factual | 5 | 2019 | 683 | 0.370 |
Why?
|
| Pregnant Women | 2 | 2023 | 79 | 0.370 |
Why?
|
| Commerce | 2 | 2021 | 47 | 0.360 |
Why?
|
| Retrospective Studies | 6 | 2022 | 6459 | 0.340 |
Why?
|
| Health Insurance Exchanges | 2 | 2019 | 3 | 0.320 |
Why?
|
| Delivery of Health Care | 2 | 2022 | 325 | 0.280 |
Why?
|
| Pregnancy Complications | 2 | 2021 | 387 | 0.270 |
Why?
|
| Patient Discharge | 2 | 2019 | 353 | 0.260 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2018 | 331 | 0.260 |
Why?
|
| Morbidity | 2 | 2022 | 149 | 0.250 |
Why?
|
| Sex Factors | 2 | 2019 | 766 | 0.240 |
Why?
|
| Comorbidity | 4 | 2020 | 664 | 0.230 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2023 | 25 | 0.220 |
Why?
|
| Parturition | 2 | 2022 | 53 | 0.220 |
Why?
|
| Minority Groups | 1 | 2023 | 136 | 0.210 |
Why?
|
| Long-Term Care | 1 | 2022 | 59 | 0.210 |
Why?
|
| Health Care Surveys | 2 | 2020 | 195 | 0.210 |
Why?
|
| Prenatal Care | 1 | 2023 | 118 | 0.210 |
Why?
|
| Health Care Costs | 2 | 2023 | 175 | 0.200 |
Why?
|
| Psychotherapy | 2 | 2019 | 106 | 0.200 |
Why?
|
| Maryland | 1 | 2021 | 34 | 0.200 |
Why?
|
| Disabled Persons | 1 | 2022 | 105 | 0.200 |
Why?
|
| Bronchitis | 1 | 2020 | 11 | 0.200 |
Why?
|
| Marketing | 1 | 2021 | 27 | 0.190 |
Why?
|
| Income | 1 | 2021 | 102 | 0.190 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2020 | 34 | 0.190 |
Why?
|
| Tobacco, Smokeless | 1 | 2020 | 27 | 0.190 |
Why?
|
| Crime | 1 | 2020 | 29 | 0.180 |
Why?
|
| Prescriptions | 1 | 2019 | 9 | 0.180 |
Why?
|
| Preferred Provider Organizations | 1 | 2019 | 2 | 0.180 |
Why?
|
| Child, Preschool | 2 | 2019 | 4158 | 0.180 |
Why?
|
| Health Maintenance Organizations | 1 | 2019 | 19 | 0.180 |
Why?
|
| Narcotic Antagonists | 1 | 2020 | 126 | 0.180 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2019 | 88 | 0.170 |
Why?
|
| Arthritis | 1 | 2019 | 49 | 0.170 |
Why?
|
| Spouses | 1 | 2019 | 13 | 0.170 |
Why?
|
| Back Pain | 1 | 2019 | 44 | 0.170 |
Why?
|
| Body Weight | 2 | 2013 | 578 | 0.170 |
Why?
|
| Residential Treatment | 1 | 2018 | 16 | 0.170 |
Why?
|
| Migraine Disorders | 1 | 2019 | 49 | 0.170 |
Why?
|
| Methadone | 1 | 2019 | 169 | 0.170 |
Why?
|
| Outpatients | 1 | 2019 | 122 | 0.170 |
Why?
|
| Nicotine | 1 | 2020 | 205 | 0.170 |
Why?
|
| Risk Factors | 2 | 2019 | 3937 | 0.170 |
Why?
|
| Private Sector | 1 | 2018 | 9 | 0.170 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 172 | 0.160 |
Why?
|
| Psychotropic Drugs | 1 | 2019 | 82 | 0.160 |
Why?
|
| Tobacco Products | 1 | 2020 | 115 | 0.160 |
Why?
|
| Tobacco Use Disorder | 1 | 2020 | 183 | 0.160 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 643 | 0.160 |
Why?
|
| Sex Distribution | 1 | 2018 | 159 | 0.160 |
Why?
|
| Age Distribution | 1 | 2018 | 199 | 0.160 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2018 | 52 | 0.160 |
Why?
|
| Prevalence | 1 | 2021 | 1025 | 0.150 |
Why?
|
| Health Policy | 1 | 2018 | 171 | 0.150 |
Why?
|
| Health Services Needs and Demand | 1 | 2019 | 190 | 0.150 |
Why?
|
| Students | 1 | 2019 | 209 | 0.150 |
Why?
|
| Benzodiazepines | 1 | 2016 | 70 | 0.140 |
Why?
|
| Quality of Life | 1 | 2022 | 924 | 0.140 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2015 | 70 | 0.130 |
Why?
|
| Aged | 6 | 2023 | 10060 | 0.130 |
Why?
|
| Cyclopropanes | 1 | 2015 | 19 | 0.130 |
Why?
|
| Sulfides | 1 | 2015 | 32 | 0.130 |
Why?
|
| Socioeconomic Factors | 4 | 2020 | 639 | 0.130 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2015 | 31 | 0.130 |
Why?
|
| Antidepressive Agents | 1 | 2016 | 187 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 369 | 0.130 |
Why?
|
| Arkansas | 4 | 2023 | 2100 | 0.120 |
Why?
|
| Patient Admission | 1 | 2014 | 78 | 0.120 |
Why?
|
| Patient Transfer | 1 | 2014 | 102 | 0.120 |
Why?
|
| Obesity, Morbid | 1 | 2014 | 88 | 0.120 |
Why?
|
| Nursing Homes | 1 | 2014 | 126 | 0.120 |
Why?
|
| Body Height | 1 | 2013 | 76 | 0.120 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 1696 | 0.120 |
Why?
|
| Health Status | 1 | 2015 | 368 | 0.110 |
Why?
|
| Stereotyping | 1 | 2013 | 41 | 0.110 |
Why?
|
| Body Mass Index | 2 | 2013 | 712 | 0.110 |
Why?
|
| Interviews as Topic | 1 | 2013 | 314 | 0.110 |
Why?
|
| Time Factors | 1 | 2019 | 3210 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1229 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 2 | 2023 | 291 | 0.080 |
Why?
|
| Smoking | 1 | 2009 | 552 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2023 | 2923 | 0.060 |
Why?
|
| West Virginia | 1 | 2023 | 3 | 0.060 |
Why?
|
| Insurance | 1 | 2021 | 8 | 0.050 |
Why?
|
| Minority Health | 1 | 2021 | 11 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2022 | 136 | 0.050 |
Why?
|
| Pregnancy Outcome | 1 | 2023 | 248 | 0.050 |
Why?
|
| Medicare | 1 | 2023 | 245 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2021 | 125 | 0.050 |
Why?
|
| Term Birth | 1 | 2020 | 21 | 0.050 |
Why?
|
| Cost Sharing | 1 | 2019 | 18 | 0.040 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2018 | 46 | 0.040 |
Why?
|
| Insurance Claim Review | 1 | 2018 | 28 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 218 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2019 | 133 | 0.040 |
Why?
|
| Premature Birth | 1 | 2020 | 154 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2020 | 239 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2020 | 293 | 0.040 |
Why?
|
| Smoking Cessation | 1 | 2020 | 311 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1082 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 309 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2020 | 1546 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 2606 | 0.030 |
Why?
|
| Disease | 1 | 2015 | 28 | 0.030 |
Why?
|
| Hypertension | 1 | 2020 | 565 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2014 | 35 | 0.030 |
Why?
|
| Infant | 1 | 2023 | 3829 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 3431 | 0.030 |
Why?
|
| Neoplasms | 1 | 2020 | 1322 | 0.020 |
Why?
|
| China | 1 | 2009 | 104 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 445 | 0.020 |
Why?
|